Patents by Inventor Michael G. Meyer

Michael G. Meyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11885732
    Abstract: A classification training method for training classifiers adapted to identify specific mutations associated with different cancer including identifying driver mutations. First cells from mutation cell lines derived from conditions having the number of driver mutations are acquired and 3D image feature data from the number of first cells is identified. 3D cell imaging data from the number of first cells and from other malignant cells is generated, where cell imaging data includes a number of first individual cell images. A second set of 3D cell imaging data is generated from a set of normal cells where the number of driver mutations are expected to occur, where the second set of cell imaging data includes second individual cell images. Supervised learning is conducted based on cell line status as ground truth to generate a classifier.
    Type: Grant
    Filed: October 18, 2022
    Date of Patent: January 30, 2024
    Assignee: VisionGate, Inc.
    Inventors: Michael G. Meyer, Daniel J. Sussman, Rahul Katdare, Laimonas Kelbauskas, Alan C. Nelson, Randall Mastrangelo
  • Patent number: 11835064
    Abstract: A gas turbine engine comprises an engine core and an electric fan array. The engine core includes a compressor, a combustor, and a turbine. The compressor compresses and delivers air to the combustor. The combustor mixes fuel with the compressed air received from the compressor and ignites the fuel. The hot, high-pressure products of the combustion reaction in the combustor are directed into the turbine to cause the turbine to rotate about an axis and drive the compressor. The electric fan array may include at least two non-concentric fans having parallel shafts.
    Type: Grant
    Filed: December 27, 2022
    Date of Patent: December 5, 2023
    Assignees: Rolls-Royce North American Technologies Inc., Rolls-Royce Corporation
    Inventors: Robert W. Heeter, Daniel E. Molnar, Jr., Kathryn A. Sontag, Michael G. Meyer
  • Publication number: 20230289407
    Abstract: A method for a system and method for morphometric detection of malignancy associated change (MAC) is disclosed including the acts of obtaining a sample; imaging cells to produce 3D cell images for each cell; measuring a plurality of different structural biosignatures for each cell from its 3D cell image to produce feature data; analyzing the feature data by first using cancer case status as ground truth to supervise development of a classifier to test the degree to which the features discriminate between cells from normal or cancer patients; using the analyzed feature data to develop classifiers including, a first classifier to discriminate normal squamous cells from normal and cancer patients, a second classifier to discriminate normal macrophages from normal and cancer patients, and a third classifier to discriminate normal bronchial columnar cells from normal and cancer patients.
    Type: Application
    Filed: December 12, 2022
    Publication date: September 14, 2023
    Inventors: Michael G. Meyer, Laimonas Kelbauskas, Rahul Katdare, Daniel J. Sussman, Timothy Bell, Alan C. Nelson
  • Publication number: 20230050322
    Abstract: A classification training method for training classifiers adapted to identify specific mutations associated with different cancer including identifying driver mutations. First cells from mutation cell lines derived from conditions having the number of driver mutations are acquired and 3D image feature data from the number of first cells is identified. 3D cell imaging data from the number of first cells and from other malignant cells is generated, where cell imaging data includes a number of first individual cell images. A second set of 3D cell imaging data is generated from a set of normal cells where the number of driver mutations are expected to occur, where the second set of cell imaging data includes second individual cell images. Supervised learning is conducted based on cell line status as ground truth to generate a classifier.
    Type: Application
    Filed: October 18, 2022
    Publication date: February 16, 2023
    Inventors: Michael G. Meyer, Daniel J. Sussman, Rahul Katdare, Laimonis Kelbauskas, Alan C. Nelson, Randall Mastrangelo
  • Patent number: 11551043
    Abstract: A method for a system and method for morphometric detection of malignancy associated change (MAC) is disclosed including the acts of obtaining a sample; imaging cells to produce 3D cell images for each cell; measuring a plurality of different structural biosignatures for each cell from its 3D cell image to produce feature data; analyzing the feature data by first using cancer case status as ground truth to supervise development of a classifier to test the degree to which the features discriminate between cells from normal or cancer patients; using the analyzed feature data to develop classifiers including, a first classifier to discriminate normal squamous cells from normal and cancer patients, a second classifier to discriminate normal macrophages from normal and cancer patients, and a third classifier to discriminate normal bronchial columnar cells from normal and cancer patients.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: January 10, 2023
    Assignee: VISIONGATE, INC.
    Inventors: Michael G. Meyer, Laimonas Kelbauskas, Rahul Katdare, Daniel J. Sussman, Timothy Bell, Alan C. Nelson
  • Patent number: 11545237
    Abstract: A classification training method for training classifiers adapted to identify specific mutations associated with different cancer including identifying driver mutations. First cells from mutation cell lines derived from conditions having the number of driver mutations are acquired and 3D image feature data from the number of first cells is identified. 3D cell imaging data from the number of first cells and from other malignant cells is generated, where cell imaging data includes a number of first individual cell images. A second set of 3D cell imaging data is generated from a set of normal cells where the number of driver mutations are expected to occur, where the second set of cell imaging data includes second individual cell images. Supervised learning is conducted based on cell line status as ground truth to generate a classifier.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: January 3, 2023
    Assignee: VISIONGATE, INC.
    Inventors: Michael G. Meyer, Daniel J. Sussman, Rahul Katdare, Laimonas Kelbauskas, Alan C. Nelson, Randall Mastrangelo
  • Patent number: 11069054
    Abstract: A method of treating a malignancy in a human subject by analyzing pseudo-projection images of cells obtained from a sputum specimen obtained from a subject employs a biological specimen classifier that identifies cells from the sputum specimen as normal or abnormal. If abnormal cells are detected, then the abnormal cells are further classified as dysplastic or cancerous. If the cells are classified as dysplastic, then an immunomodulating agent is administered to the subject over a predetermined time period designed to achieve a therapeutic dosage.
    Type: Grant
    Filed: January 11, 2017
    Date of Patent: July 20, 2021
    Assignee: VisionGate, Inc.
    Inventors: Alan C. Nelson, Michael G. Meyer, Daniel J. Sussman
  • Publication number: 20210210169
    Abstract: A classification training method for training classifiers adapted to identify specific mutations associated with different cancer including identifying driver mutations. First cells from mutation cell lines derived from conditions having the number of driver mutations are acquired and 3D image feature data from the number of first cells is identified. 3D cell imaging data from the number of first cells and from other malignant cells is generated, where cell imaging data includes a number of first individual cell images. A second set of 3D cell imaging data is generated from a set of normal cells where the number of driver mutations are expected to occur, where the second set of cell imaging data includes second individual cell images. Supervised learning is conducted based on cell line status as ground truth to generate a classifier.
    Type: Application
    Filed: September 26, 2018
    Publication date: July 8, 2021
    Applicant: VISIONGATE, INC.
    Inventors: Michael G. MEYER, Daniel J. SUSSMAN, Rahul KATDARE, Laimonis KELBAUSKAS, Alan C. NELSON, Randall MASTRANGELO
  • Publication number: 20210200987
    Abstract: A method to develop one or more morphometric classifiers to identify a mismatch repair deficiency (MMRD). The method provides a non-invasive method of characterizing MMRD that is responsive to a tumor in its early stages of development and irrespective of the tumor size. The method allows targeting cancer therapy to the specific characteristics of the cancer that the patient may have, allowing more efficient cancer management with far fewer side effects.
    Type: Application
    Filed: June 5, 2019
    Publication date: July 1, 2021
    Applicant: VISIONGATE, INC.
    Inventors: Daniel J. Sussman, Michael G. Meyer, Randall Mastrangelo, Alan C. Nelson
  • Publication number: 20210049425
    Abstract: A method for a system and method for morphometric detection of malignancy associated change (MAC) is disclosed including the acts of obtaining a sample; imaging cells to produce 3D cell images for each cell; measuring a plurality of different structural biosignatures for each cell from its 3D cell image to produce feature data; analyzing the feature data by first using cancer case status as ground truth to supervise development of a classifier to test the degree to which the features discriminate between cells from normal or cancer patients; using the analyzed feature data to develop classifiers including, a first classifier to discriminate normal squamous cells from normal and cancer patients, a second classifier to discriminate normal macrophages from normal and cancer patients, and a third classifier to discriminate normal bronchial columnar cells from normal and cancer patients.
    Type: Application
    Filed: February 28, 2019
    Publication date: February 18, 2021
    Applicant: VISIONGATE, INC.
    Inventors: Michael G. Meyer, Laimonis Kelbauskas, Rahul Katdare, Daniel J. Sussman, Timothy Bell, Alan C. Nelson
  • Patent number: 10697320
    Abstract: A gas turbine engine assembly includes a static component and a rotatable component configured to rotate about a central axis of the gas turbine engine assembly relative to the static component. The gas turbine engine assembly further includes a vibration-dampening system configured to dampen vibration of the gas turbine engine assembly.
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: June 30, 2020
    Assignee: Rolls-Royce Corporation
    Inventors: Roy D. Fulayter, Michael G. Meyer
  • Publication number: 20180209345
    Abstract: A gas turbine engine assembly includes a static component and a rotatable component configured to rotate about a central axis of the gas turbine engine assembly relative to the static component. The gas turbine engine assembly further includes a vibration-dampening system configured to dampen vibration of the gas turbine engine assembly.
    Type: Application
    Filed: January 10, 2018
    Publication date: July 26, 2018
    Inventors: Roy D. Fulayter, Michael G. Meyer
  • Publication number: 20170140533
    Abstract: A method of treating a malignancy in a human subject by analyzing pseudo-projection images of cells obtained from a sputum specimen obtained from a subject employs a biological specimen classifier that identifies cells from the sputum specimen as normal or abnormal. If abnormal cells are detected, then the abnormal cells are further classified as dysplastic or cancerous. If the cells are classified as dysplastic, then an immunomodulating agent is administered to the subject over a predetermined time period designed to achieve a therapeutic dosage.
    Type: Application
    Filed: January 11, 2017
    Publication date: May 18, 2017
    Applicant: VISIONGATE, INC.
    Inventors: Alan C. Nelson, Michael G. Meyer
  • Patent number: 9594072
    Abstract: A cytological analysis test for 3D cell classification from a specimen. The method includes isolating and preserving a cell from the specimen and enriching the cell before embedding the enriched cell into an optical medium. The embedded cell is injected into a capillary tube where pressure is applied until the cell appears in a field of view of a pseudo-projection viewing subsystem to acquire a pseudo-projection image. The capillary tube rotates about a tube axis to provide a set of pseudo-projection images for each embedded cell which are reconstructed to produce a set of 3D cell reconstructions. Reference cells are classified and enumerated and a second cell classifier detects target cells. An adequacy classifier compares the number of reference cells against a threshold value of enumerated reference cells to determine specimen adequacy.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: March 14, 2017
    Assignee: VISIONGATE, INC.
    Inventors: Michael G. Meyer, Rahul Katdare, Chris Presley, Timothy Bell
  • Publication number: 20170003267
    Abstract: A cytological analysis test for 3D cell classification from a specimen. The method includes isolating and preserving a cell from the specimen and enriching the cell before embedding the enriched cell into an optical medium. The embedded cell is injected into a capillary tube where pressure is applied until the cell appears in a field of view of a pseudo-projection viewing subsystem to acquire a pseudo-projection image. The capillary tube rotates about a tube axis to provide a set of pseudo-projection images for each embedded cell which are reconstructed to produce a set of 3D cell reconstructions. Reference cells are classified and enumerated and a second cell classifier detects target cells. An adequacy classifier compares the number of reference cells against a threshold value of enumerated reference cells to determine specimen adequacy.
    Type: Application
    Filed: June 30, 2015
    Publication date: January 5, 2017
    Applicant: VISIONGATE, INC.
    Inventors: Michael G. Meyer, Rahul Katdare, Chris Presley, Timothy Bell
  • Patent number: 8947510
    Abstract: A method for 3D imaging of a biologic object (1) in an optical tomography system where a subcellular structure of a biological object (1) is labeled by introducing at least one nanoparticle-biomarker. The labeled biological object (1) is moved relatively to a microscope objective (62) to present varying angles of view and the labeled biological object (1) is illuminated with radiation having wavelengths between 150 nm and 900 nm. Radiation transmitted through the labeled biological object (1) and the microscope objective (62) within at least one wavelength bands is sensed with a color camera, or with a set of at least four monochrome cameras. A plurality of cross-sectional images of the biological object (1) from the sensed radiation is formed and reconstructed to make a 3D image of the labeled biological object (1).
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: February 3, 2015
    Assignee: Visiongate, Inc.
    Inventors: Michael G. Meyer, J. Richard Rahn, Anna V. Tourovskaia, Julia Oi Yan Yu, Christy A Lancaster, Thomas Neumann, Mark E. Fauver
  • Publication number: 20120105600
    Abstract: A method for 3D imaging of a biologic object (1) in an optical tomography system where a subcellular structure of a biological object (1) is labeled by introducing at least one nanoparticle-biomarker. The labeled biological object (1) is moved relatively to a microscope objective (62) to present varying angles of view and the labeled biological object (1) is illuminated with radiation having wavelengths between 150 nm and 900 nm. Radiation transmitted through the labeled biological object (1) and the microscope objective (62) within at least one wavelength bands is sensed with a color camera, or with a set of at least four monochrome cameras. A plurality of cross-sectional images of the biological object (1) from the sensed radiation is formed and reconstructed to make a 3D image of the labeled biological object (1).
    Type: Application
    Filed: June 8, 2009
    Publication date: May 3, 2012
    Inventors: Michael G. Meyer, J. Richard Rahn, Anna V. Tourovskaia, Julia Oi Yan Yu, Christy A. Lancaster, Thomas Neumann, Mark E. Fauver
  • Patent number: 8155420
    Abstract: A system and method for detecting poor quality images in an optical tomography system includes an acquisition apparatus for acquiring a set of pseudo-projection images of an object having a center of mass, where each of the set of pseudo-projection images is acquired at a different angle of view. A reconstruction apparatus is coupled to receive the pseudo-projection images, for reconstruction of the pseudo-projection images into 3D reconstruction images. A quality apparatus is coupled to receive the 3D reconstruction images and operates to detect of selected features that characterize poor quality reconstructions.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: April 10, 2012
    Assignee: Visiongate, Inc
    Inventors: Michael G. Meyer, Rahul Katdare, David Ethan Steinhauer, J. Richard Rahn
  • Patent number: 8090183
    Abstract: Correcting pattern noise projection images includes acquiring a set of projection images with an optical tomography system including a processor, where each of the set of projection images is acquired at a different angle of view. A threshold is applied to each projection image produce a set of threshold images. Each threshold image may optionally be dilated to produce a set of dilated images that are summed to form an ensemble image. Each of the dilated images is processed to produce a set of binary images. The set of binary images are summed to form an ensemble mask. The ensemble image is divided by the ensemble mask to yield a background pattern noise image. Each projection image is multiplied by a scaling factor and divided by the background pattern noise to produce a quotient image that is filtered to produce a noise corrected projection image.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: January 3, 2012
    Assignee: Visiongate, Inc.
    Inventors: Michael G. Meyer, Jon W. Hayenga, Thomas M. Abbott, David E. Steinhauer
  • Patent number: 7907765
    Abstract: An optical tomography system for imaging an object of interest including a light source for illuminating the object of interest with a plurality of radiation beams. The object of interest is held within an object containing tube such that it is illuminated by the plurality of radiation beams to produce emerging radiation from the object containing tube, a detector array is located to receive the emerging radiation and produce imaging data used by a mechanism for tracking the object of interest.
    Type: Grant
    Filed: September 18, 2006
    Date of Patent: March 15, 2011
    Assignees: University of Washington, Visiongate, Inc.
    Inventors: Mark E. Fauver, Eric J. Seibel, Michael G. Meyer, Alan C. Nelson, J. Richard Rahn, Thomas Neumann, Roger H. Johnson